EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus



Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus



Lancet. Infectious Diseases 17(6): 645-653



Label="BACKGROUND">The frequency of asymptomatic infection with Ebola virus is unclear: previous estimates vary and there is no standard test. Asymptomatic infection with Ebola virus could contribute to population immunity, reducing spread. If people with asymptomatic infection are infectious it could explain re-emergences of Ebola virus disease (EVD) without known contact.Label="METHODS">We validated a new oral fluid anti-glycoprotein IgG capture assay among survivors from Kerry Town Ebola Treatment Centre and controls from communities unaffected by EVD in Sierra Leone. We then assessed the seroprevalence of antibodies to Ebola virus in a cross-sectional study of household contacts of the survivors. All household members were interviewed. Two reactive tests were required for a positive result, with a third test to resolve any discrepancies.Label="FINDINGS">The assay had a specificity of 100% (95% CI 98·9-100; 339 of 339 controls tested negative) and sensitivity of 95·9% (89·8-98·9; 93 of 97 PCR-confirmed survivors tested positive). Of household contacts not diagnosed with EVD, 47·6% (229 of 481) had high level exposure (direct contact with a corpse, body fluids, or a case with diarrhoea, vomiting, or bleeding). Among the contacts, 12·0% (95% CI 6·1-20·4; 11 of 92) with symptoms at the time other household members had EVD, and 2·6% (1·2-4·7; 10 of 388) with no symptoms tested positive. Among asymptomatic contacts, seropositivity was weakly correlated with exposure level.Label="INTERPRETATION">This new highly specific and sensitive assay showed asymptomatic infection with Ebola virus was uncommon despite high exposure. The low prevalence suggests asymptomatic infection contributes little to herd immunity in Ebola, and even if infectious, would account for few transmissions.Label="FUNDING">Wellcome Trust ERAES Programme, Save the Children.

(PDF emailed within 0-6 h: $19.90)

Accession: 059420640

Download citation: RISBibTeXText

PMID: 28256310

DOI: 10.1016/S1473-3099(17)30111-1



Related references

Viraemia and Ebola virus secretion in survivors of Ebola virus disease in Sierra Leone: a cross-sectional cohort study. Lancet. Infectious Diseases 16(9): 1052-1056, 2017

Exposure-Specific and Age-Specific Attack Rates for Ebola Virus Disease in Ebola-Affected Households, Sierra Leone. Emerging Infectious Diseases 22(8): 1403-1411, 2018

Performance of the GeneXpert Ebola Assay for Diagnosis of Ebola Virus Disease in Sierra Leone: A Field Evaluation Study. Plos Medicine 13(3): E1001980-E1001980, 2016

Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui Government Hospital in Sierra Leone during the 2014 Ebola outbreak. European Journal of Clinical Microbiology & Infectious Diseases 34(10): 2089-2095, 2016

Field Laboratory Evaluation of the GeneXpert Ebola Assay for Diagnosis of Ebola Virus Disease in Sierra Leone. Open Forum Infectious Diseases 2(Suppl 1): -, 2016

The major progress on the Ebola virus disease study and international Ebola virus testing in Sierra Leone. Zhonghua Liu Xing Bing Xue Za Zhi 36(9): 1023-1025, 2016

Bacterial co-infection is rare in patients with Ebola virus disease in a military Ebola virus disease treatment unit in Sierra Leone. Journal of Infection 71(3): 406-407, 2016

Implementation of a study to examine the persistence of Ebola virus in the body fluids of Ebola virus disease survivors in Sierra Leone: Methodology and lessons learned. Plos Neglected Tropical Diseases 11(9): E0005723-E0005723, 2017

Development of risk reduction behavioral counseling for Ebola virus disease survivors enrolled in the Sierra Leone Ebola Virus Persistence Study, 2015-2016. Plos Neglected Tropical Diseases 11(9): E0005827-E0005827, 2017

Comparison of international Ebola virus testing laboratories in Ebola virus disease outbreak in Sierra Leone. Zhonghua Liu Xing Bing Xue Za Zhi 36(9): 1034-1037, 2016

Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet. Infectious Diseases 16(3): 331-338, 2016

Prevalence of psychological symptoms among Ebola survivors and healthcare workers during the 2014-2015 Ebola outbreak in Sierra Leone: a cross-sectional study. Oncotarget 8(8): 12784-12791, 2017

The etiology of Ebola virus disease-like illnesses in Ebola virusnegative patients from Sierra Leone. Oncotarget 7(19): 27910-5, 2017

Diagnosis of Febrile Illnesses Other Than Ebola Virus Disease at an Ebola Treatment Unit in Sierra Leone. Clinical Infectious Diseases 61(5): 795-798, 2016

Risk in the "Red Zone": Outcomes for Children Admitted to Ebola Holding Units in Sierra Leone Without Ebola Virus Disease. Clinical Infectious Diseases 65(1): 162-165, 2017